title: Cerebral microbleeds: is antithrombotic therapy safe to administer?
authors.affiliation: From the Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
authors.forename: Zhaolu
authors.initials: Z
authors.lastname: Wang
authors.affiliation: From the Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
authors.forename: Yannie O Y
authors.initials: YO
authors.lastname: Soo
authors.affiliation: From the Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. vctmok@cuhk.edu.hk.
authors.forename: Vincent C T
authors.initials: VC
authors.lastname: Mok
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000150:complications / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D016017:Odds Ratio; D061214:Patient Safety; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D020521:Stroke / Q000150:complications / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors
keywords: hemorrhage